SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Henningfield JE, Grundmann O, Babin JK, Fant RV, Wang DW, Cone EJ. Prev. Med. 2019; ePub(ePub): ePub.

Affiliation

PInneyAssociates, Bethesda, MD, United States of America; The Johns Hopkins University School of Medicine, United States of America.

Copyright

(Copyright © 2019, Elsevier Publishing)

DOI

10.1016/j.ypmed.2019.105851

PMID

31647958

Abstract

Kratom use appears to be increasing across the United States, increasing attention to deaths in which kratom use was detected. Most such deaths have been ascribed to fentanyl, heroin, benzodiazepines, prescription opioids, cocaine and other causes (e.g., homicide, suicide and various preexisting diseases). Because kratom has certain opioid-like effects (e.g., pain relief), and is used by some people as a substitute for opioids for pain or addiction, kratom has been compared to "narcotic-like opioids" (e.g., morphine) with respect to risk of death despite evidence that its primary alkaloid, mitragynine, carries little of the signature respiratory depressing effects of morphine-like opioids. This commentary summarizes animal toxicology data, surveys and mortality data associated with opioids and kratom to provide a basis for estimating relative mortality risk. Population-level mortality estimates attributed to opioids as compared to kratom, and the per user mortality risks of opioids as compared to kratom are provided. By any of our assessments, it appears that the risk of overdose death is >1000 times greater for opioids than for kratom. The limitations of the mortality risk estimate warrants caution in individuals with unknown factors such as use of other substances and medications, or other preexisting conditions. More research on kratom safety and risks is needed, as is regulation of commercial kratom products to ensure that consumers are informed by FDA labeling and that kratom products are not contaminated or adulterated with other substances.

Copyright © 2018. Published by Elsevier Inc.


Language: en

Keywords

Kratom; Mitragynine; Mortality risk; Opioid epidemic; Opioids

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print